- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT02108041
Tomada de decisões de medicina personalizada em um ambiente clínico virtual
Tomada de decisões médicas em um ambiente clínico virtual
Background:
-How people respond to drugs depends in part on their genes. For some drugs, doctors can use an individuals genetic background to help in dosing the drug. Researchers want to know how doctors incorporate personalized or genomic medicine into clinical practice.
Objective:
-To study how physicians make personalized treatment decisions
Eligibility:
-Healthy adult primary care physicians who are internal (or family) medicine residents.
Design:
- Participants will complete a screening form.
- Participants will put on a headset, called a head-mounted display, showing a virtual reality environment.
- The environment will contain an exam room and the virtual patient.
- After interacting with the virtual patient, participants will complete a series of survey measures.
- Participation will last for about 60 minutes. The virtual patient interaction and follow-up questions will be audio taped.
Visão geral do estudo
Status
Condições
Descrição detalhada
This study will examine factors related to primary care physicians clinical decision-making. Using a virtual clinical interaction experiment, we aim to better understand physicians decision-making processes and to explore their communication behaviors toward patients in the clinical encounter. Physician participants will enter a virtual exam room where they will be asked to respond to a virtual patient, acting as her primary care physician in a follow-up visit to evaluate her for depression. Various aspects of physician communication in the virtual clinic and self-report measures related to decision-making will be analyzed.
Tipo de estudo
Inscrição (Real)
Contactos e Locais
Locais de estudo
-
-
Maryland
-
Baltimore, Maryland, Estados Unidos, 21205
- Johns Hopkins School of Medicine
-
-
Massachusetts
-
Boston, Massachusetts, Estados Unidos, 02115
- Harvard School of Public Health
-
-
Michigan
-
Flint, Michigan, Estados Unidos
- Michigan State University
-
-
New York
-
New York, New York, Estados Unidos, 10032-3784
- Columbia University
-
-
Oregon
-
Eugene, Oregon, Estados Unidos
- University of Oregon
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Método de amostragem
População do estudo
Internal medicine and family medicine residents will be recruited from diverse national sites for the study, and the virtual reality environment will be brought to them through the use of a head-mounted display and laptop
Descrição
- INCLUSION CRITERIA:
- All physicians will be healthy adult volunteers who are medical residents in the internal medicine specialty.
EXCLUSION CRITERIA:
- persons with seizure or vestibular disorders;
- persons who are highly prone to motion sickness;
- those without normal or normal to corrected vision or hearing;
- all current and past employees and contractors of NHGRI; and
- persons who have received information about the study purpose or procedure from a past participant.
NHGRI employees are excluded for this protocol because they are likely to have specialized genomic knowledge and may think differently about genomics in the clinical interaction.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Modelos de observação: CASE_CONTROL
- Perspectivas de Tempo: CROSS_SECTIONAL
Coortes e Intervenções
Grupo / Coorte |
|---|
|
Physicians that interact with the black/High SES avatar patien
Medical residents will then be randomized to be exposed to a virtual patient with one of 4 race/SES profiles, this one being a female patient who is Upper-Middle Income and Black/African American. |
|
Physicians that interact with the black/Low SES avatar patient
Medical residents will then be randomized to be exposed to a virtual patient with one of 4 race/SES profiles, this one being a female patient who is low-Middle Income and Black/African American. |
|
Physicians that interact with the white race/high SES avatar
Medical residents will then be randomized to be exposed to a virtual patient with one of 4 race/SES profiles, this one being a female patient who is Upper-Middle Income White andCaucasian. |
|
Physicians that interact with the white race/low SES avatar p
Medical residents will then be randomized to be exposed to a virtual patient with one of 4 race/SES profiles, this one being a female patient who is low Income White and Caucasian. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
To explore how physicians use genetic testing for anticoagulant (warfarin) dosage in patients of different racial/ethnic and SES backgrounds
Prazo: Outcome measurements are assessed on the same date of the study visit.
|
To explore how physicians use genetic testing for anticoagulant (warfarin) dosage in patients of different racial /ethnic and SES backgrounds |
Outcome measurements are assessed on the same date of the study visit.
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Susan J Persky, Ph.D., National Human Genome Research Institute (NHGRI)
Publicações e links úteis
Publicações Gerais
- Green AR, Carney DR, Pallin DJ, Ngo LH, Raymond KL, Iezzoni LI, Banaji MR. Implicit bias among physicians and its prediction of thrombolysis decisions for black and white patients. J Gen Intern Med. 2007 Sep;22(9):1231-8. doi: 10.1007/s11606-007-0258-5. Epub 2007 Jun 27.
- Armstrong K. Genomics and health care disparities: the role of statistical discrimination. JAMA. 2012 Nov 21;308(19):1979-80. doi: 10.1001/2012.jama.10820. No abstract available.
Datas de registro do estudo
Datas Principais do Estudo
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimado)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 999914075
- 14-HG-N075
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
We will provide data contingent on special requests form other researchers.
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .